114
Views
3
CrossRef citations to date
0
Altmetric
Brief Communication

Virulence of MRSA USA300 is enhanced by sub-inhibitory concentration of two different classes of antibiotics

, , , &
Pages 384-388 | Received 27 Apr 2018, Accepted 01 Oct 2018, Published online: 19 Jan 2019
 

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 is responsible of many kinds of infections of skin and soft-tissue. Antibiotic resistance, biofilm formation and the ability to adhere and invade are virulence factors that contribute to MRSA pathogenesis. In some cases, decreased bioavailability of antibiotics in systemic circulation could result; in these conditions sub-therapeutic levels of the antibiotics may be established, exposing bacteria to sub-inhibitory concentrations. On the basis of several published scientific data it is fair to assume that all these events could induce an increase of bacterial virulence. In the present study, we investigated this process by measuring the effects of low doses of two different classes of antibiotics on some virulence features of MRSA USA300 isolate, like the ability to adhere and invade eukaryotic cells. Results obtained strongly support the importance of the respect of a correct dosage of antibiotic in therapy to escape the insurgence of more virulent phenotypes.

Acknowledgments

This work was supported by grant of Ministero dell’Istruzione dell’Università e della Ricerca: PON “Ricerca e Competitività 2007 – 2013, D.D. Prot. 1/Ric 18/01/2010 (Progetto PON01_01802: Development of new drugs modulating intracellular redox-regulated pathways for prevention and therapy of infective, oncologic and neurodegenerative diseases, and their delivery by nanotechnological approaches).

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.